GeekWire
Menu
  • Home
  • News
    • Amazon
    • Civic presented by Microsoft
    • Geek Life presented by Network of Giving
    • Health/Life Sciences
    • Microsoft
    • Podcasts
    • Space
    • Startups
    • Sustainability
    • Tech Moves
    • Bot or Not
    • GeekWire on the Road: Spokane
    • Microsoft at 50 presented by Accenture
    • Tech Vets presented by Northern Trust
  • GeekWork
    • GeekWork Recruiting
    • Job Board
  • Events
    • Community Calendar
    • GeekWire Events
  • Lists
    • Amazon Office Buildings
    • GeekWire 200 presented by JPMorganChase
    • GeekWire Startup List
    • GeekWire Startup Resources
    • GeekWire Startup Spaces
    • Layoff Tracker
    • M&As and IPOs
    • Northwest Women VC & Angel Investor List
    • Recent Fundings
    • Seattle Engineering Outposts
    • Venture Capital Directory
  • Members
    • Health Benefits
    • Memberships
  • Studios
    • GeekWire Studios: Let Us Tell Your Story
    • Nebius at NVIDIA GTC 2025 sponsored by Nebius
    • AWS Marketplace Seller Conference 2024 sponsored by AWS
    • AWS Summit: New York Partner Spotlights sponsored by AWS
    • Does Compute presented by Carnegie Mellon University
    • Guide to re:Invent sponsored by AWS
    • Money Hacks presented by BECU
    • Tech Connect at Dreamforce 2024 sponsored by RSM US LLP
    • Uncommon Thinkers Welcome sponsored by Greater Seattle Partners
    • Zuper at Inbound sponsored by Zuper
  • About
    • About GeekWire
    • Advertise
    • Contact Us
    • Email Newsletters
    • Reprints & Permissions
    • Sponsors
  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips

What happens here matters everywhere.

  • Podcast
  • LinkedIn
  • Newsletter
  • News Tips
  • Amazon
  • Microsoft
  • Startups
  • AI
  • Science
  • Tech Moves
  • Sustainability
  • Civic
  • Geek Life

Biotech

Biotech firm OncoGenex sees stock sink 40% after unsuccessful clinical trial

OncoGenex, a pharmaceutical firm based in Bothell, Wash., announced today an unsuccessful end to their phase 3 clinical trial of an… Read More

Podcast

GeekWire Radio: Olympics streaming tips, ReachNow at the Seattle airport, and more

This week on the GeekWire radio show and podcast: BMW’s ReachNow car sharing program added service to Seattle’s SeaTac Airport this week.… Read More

Leroy Hood

How biotech visionary Leroy Hood redefined the industry: Q&A with biographer Luke Timmerman

In the quest for a better understanding of the human body, the automated DNA sequencer was a breakthrough innovation, giving… Read More

Seattle biotech entrepreneur Ron Berenson raising cash for new startup

Ron Berenson has another biotechnology startup in the works, a new company by the name of DMD Therapeutics. The Seattle-based company recently… Read More

Sneak peek: New biography of biotech pioneer Leroy Hood is revealing and rigorously reported

“Mr. Gates, I Quit.” That’s the opening chapter of “Hood: Trailblazer of the Genomics Age,” and it’s just the first indication… Read More

Juno Therapeutics lab

Why biotech investments in Washington state have dropped to the lowest levels since 2011

Seattle’s biotechnology industry has never really taken root — undergoing a series of ups and downs as companies such as… Read More

Seattle just got another publicly traded biotech company

Seattle-based Aptevo Therapeutics completed a spinoff from Emergent BioSolutions Monday, making a debut in the public markets as a standalone company.… Read More

BioMed Realty opening new biotech startup space in lab-starved Seattle

Startup, co-working and incubator spaces are proliferating throughout the Puget Sound region. But Seattle isn’t just a tech town, it’s… Read More

T-cells

Alpine Immune Sciences raises $48 million for cancer and autoimmune treatment

Seattle’s Alpine Immune Sciences says it has closed a $48 million Series A financing round, to fund the development of… Read More

Defibrillator

Legacies that save lives: Washington Life Science Hall of Fame gets first members

Six medical pioneers were inducted into the newly created Washington Life Science Hall of Fame today, and although some of… Read More

Protein design

Designer proteins, created and edited on computers, open up new biotech frontiers

Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are… Read More

Cardiac Insight closes $2.5M funding round to identify heart problems in young athletes

Cardiac Insight is preparing for the launch of its CardeaScreen technology, and the company has raised $2.5 million to help spur… Read More

Telomeres

BioViva’s Liz Parrish makes progress in controversial gene quest to reverse aging

The way BioViva founder Elizabeth Parrish sees it, biological aging is a disease – and she’s willing to bet her life on a… Read More

Institute for Systems Biology joins Providence; Biotech pioneer Leroy Hood named health system’s chief science officer

The non-profit Institute for Systems Biology, a Seattle-based biomedical research organization that has spun off eight companies in the past 15 years, is joining Providence… Read More

Gene therapy biotech startup Immusoft acquires Discovery Genomics

Immusoft, a Seattle-based biotech startup that has developed a way to manipulate human immune cells, today announced the acquisition of… Read More

Charlie Sheen shows interest in CytoDyn, which just raised $33M to develop ‘functional cure’ for HIV

If you are one of the 1.2 million Americans living with HIV, your treatment options are basically limited to taking… Read More

CRISPR technology

Editas Medicine raises $94M in first gene-editing IPO, and then stock price rises

Editas Medicine’s entry into the stock market with a $94.4 million initial public offering appears to be sparking positive signals… Read More

Image: Illumina sequencer

Bill Gates and Jeff Bezos invest in Grail, Illumina’s $100M cancer testing venture

One of the giants of gene sequencing, Illumina, has spun off a new $100 million company called Grail to create… Read More

Editas' Feng Zhang with student

Gates-backed Editas Medicine files for IPO, marking CRISPR gene-editing milestone

Editas Medicine filed the paperwork for an initial public offering today, marking a first for the growing number of private… Read More

Juno Therapeutics misses expectations in Q3 with $1.6M revenue, $47.6M net loss

Juno Therapeutics missed analyst expectations with its Q3 earnings report on Tuesday, posting a net loss of $47.6 million, or… Read More

Fast-growing scientific wellness startup Arivale hires BlueKai co-founder as chief revenue officer

Arivale, the “scientific wellness” startup co-founded by genomics pioneer Lee Hood, has hired Grant Ries, the co-founder of big-data company BlueKai,… Read More

Life science investment group Accelerator Corp. completes $62.8M in funding for biotech startups

Seattle-based Accelerator Corp. will be looking to spend a ton of money on biotech startups soon, but not only in the… Read More

Washington biotech trade association CEO Chris Rivera to step down after helping to build life science community in Seattle region

Chris Rivera is stepping down as president and CEO of the Washington Biotechnology & Biomedical Association, a nonprofit biotech trade group. He… Read More

Juno Therapeutics posts $66M Q2 loss, looks to gain ground with first clinical trials

Juno Therapeutics, a Seattle-based cancer research firm backed by Amazon founder Jeff Bezos, Arch Venture Partners and others, reported a loss… Read More

Kineta wins $4M award to develop therapies against viral diseases like Ebola, influenza, others

Seattle-based biotech startup Kineta today announced that it won a $4 million federal contract from the National Institute of Allergy and… Read More

Tech Moves: Cyanogen snags Amazon exec; Veghte named SurveyMonkey CEO; Ossia expands; and more

—Cyanogen, the makers of modified versions of Android for mobile devices, has snagged two executives from Amazon and Qualcomm to expand international… Read More

Bristol-Myers Squibb relocating 40 Seattle scientists to San Francisco five years after acquiring ZymoGenetics

Five years after coming to Seattle via its purchase of ZymoGenetics, drug giant Bristol-Myers Squibb is moving 40 Seattle-based research and… Read More

Genomics pioneer Lee Hood to unveil new startup Arivale, breaking new ground in ‘scientific wellness’

Lee Hood, the genomics pioneer who has co-founded more than a dozen biotech companies, is preparing to unveil a new startup, GeekWire… Read More

Stratos Genomics raises another $15M for DNA sequencing technology

Seattle-based biotech company Stratos Genomics has raised another $15 million to complete a $30 million Series B round. Founded in… Read More

Kineta and partners raising funds to ‘break out of the old biotech model’

A consortium that includes Seattle-based biotech company Kineta, UW Medicine, and the University of Washington’s CoMotion group is seeking to raise an… Read More

  • Older
  • Newer

A Word From Our Sponsors

About

  • About GeekWire
  • Contact Us
  • Partner With Us
  • Become a GeekWire Member
  • Send Us a Tip
  • Join Our Startup List
  • Reprints and Permissions

Follow

  • Facebook
  • X
  • LinkedIn
  • Instagram
  • RSS Feed
  • Podcast
  • YouTube
  • Bluesky

GeekWire Newsletters

Catch every headline in your inbox

Read GeekWire

  • Apple News
  • Google News

Legal

  • Privacy Policy
  • Terms of Use
  • Sponsored Content Policy
Return to Top of Page
© 2011-2025 GeekWire, LLC
Do Not Sell or Share My Personal information
Limit the Use Of My Sensitive Personal Information
Consent Preferences